In the latest trading session, Teladoc (TDOC) closed at $4.85, marking a -2.61% move from the previous day. The stock trailed the S&P 500, which registered a daily loss of 0.33%. On the other hand, the Dow registered a gain of 0.1%, and the technology-centric Nasdaq decreased by 0.59%.
The telehealth services provider's stock has dropped by 31.31% in the past month, falling short of the Medical sector's loss of 1.02% and the S&P 500's loss of 0%.
The upcoming earnings release of Teladoc will be of great interest to investors. The company's earnings report is expected on February 25, 2026. The company is predicted to post an EPS of -$0.19, indicating a 32.14% growth compared to the equivalent quarter last year. At the same time, our most recent consensus estimate is projecting a revenue of $633.91 million, reflecting a 1.03% fall from the equivalent quarter last year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of -$1.19 per share and revenue of $2.52 billion. These totals would mark changes of +79.73% and -1.87%, respectively, from last year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Teladoc. These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. At present, Teladoc boasts a Zacks Rank of #3 (Hold).
The Medical Services industry is part of the Medical sector. This group has a Zacks Industry Rank of 142, putting it in the bottom 43% of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Teladoc Health, Inc. (TDOC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
